LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 868 | 683 | 3486 | 0.1959 | -0.0707 |
MCF 10A | PHA-665752 | 10.0 | uM | LJP5 | 72 | hr | 513 | 684 | 10401 | 0.0658 | 0.0173 |
Hs 578T | A443654 | 10.0 | uM | LJP6 | 72 | hr | 929 | 684 | 3228 | 0.2119 | -0.1067 |
MCF 10A | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 513 | 685 | 10401 | 0.0659 | 0.0174 |
MCF 10A | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 513 | 687 | 10401 | 0.0661 | 0.0176 |
SK-BR-3 | Geldanamycin | 10.0 | uM | LJP6 | 72 | hr | 1476 | 688 | 3694 | 0.1864 | -0.3554 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 513 | 690 | 10401 | 0.0663 | 0.0179 |
MCF 10A | A443654 | 0.37 | uM | LJP6 | 72 | hr | 513 | 692 | 10401 | 0.0666 | 0.0181 |
MDA-MB-231 | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 868 | 692 | 3486 | 0.1986 | -0.0671 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 694 | 10401 | 0.0668 | 0.0183 |
MCF 10A | CGP60474 | 1.11 | uM | LJP5 | 72 | hr | 513 | 694 | 10401 | 0.0667 | 0.0183 |
MCF7 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 694 | 4156 | 0.1671 | -0.1852 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 868 | 695 | 3486 | 0.1995 | -0.0659 |
Hs 578T | Foretinib | 10.0 | uM | LJP5 | 72 | hr | 929 | 697 | 3228 | 0.2161 | -0.1007 |
MDA-MB-231 | NVP-TAE684 | 10.0 | uM | LJP6 | 72 | hr | 868 | 698 | 3486 | 0.2003 | -0.0648 |
MCF 10A | GW843682X | 10.0 | uM | LJP6 | 72 | hr | 513 | 701 | 10401 | 0.0674 | 0.0190 |
MCF7 | HG-6-64-01 | 10.0 | uM | LJP6 | 72 | hr | 1235 | 701 | 4156 | 0.1688 | -0.1827 |
MCF 10A | GW843682X | 3.33 | uM | LJP6 | 72 | hr | 513 | 701 | 10401 | 0.0674 | 0.0190 |
MCF 10A | AZD 5438 | 3.33 | uM | LJP6 | 72 | hr | 513 | 704 | 10401 | 0.0677 | 0.0193 |
MCF 10A | Pictilisib | 10.0 | uM | LJP6 | 72 | hr | 513 | 704 | 10401 | 0.0677 | 0.0193 |
MCF7 | Seliciclib | 10.0 | uM | LJP5 | 72 | hr | 1235 | 706 | 4156 | 0.1699 | -0.1813 |
MDA-MB-231 | SB590885 | 10.0 | uM | LJP5 | 72 | hr | 868 | 706 | 3486 | 0.2026 | -0.0618 |
MCF 10A | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 513 | 712 | 10401 | 0.0685 | 0.0201 |
MDA-MB-231 | Pelitinib | 10.0 | uM | LJP5 | 72 | hr | 868 | 713 | 3486 | 0.2045 | -0.0592 |
MCF 10A | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 513 | 714 | 10401 | 0.0687 | 0.0203 |